Phenomic Email Format
Biotechnology ResearchOntario, Canada11-50 Employees
Phenomic is a biotechnology research company based in Toronto, Ontario, focused on developing therapies for stroma-rich solid tumors such as colorectal, pancreatic, and breast cancers. The organization aims to improve patient survival by addressing translational gaps that arise when conventional models fail to capture the diversity of cell types present in human tumors. To pursue this, Phenomic uses a machine learning–powered transcriptomics platform to map interactions among tumor cell types and identify drug targets, while testing candidates in human tumor explants to generate translational insights during discovery. Its lead program is a CD3 engager that employs a novel targeting approach to overcome limitations of traditional tumor-associated antigens and is at the development candidate stage.